# Feasibility of Permacol Use in Infected Fields

> **NCT00820040** · PHASE2 · TERMINATED · sponsor: **Medtronic - MITG** · enrollment: 10 (actual)

## Conditions studied

- Hernia

## Interventions

- **DEVICE:** acellular porcine dermal collagen mesh

## Key facts

- **NCT ID:** NCT00820040
- **Lead sponsor:** Medtronic - MITG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Slow enrollment due to strict eligibility criteria
- **Last updated:** 2020-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00820040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00820040, "Feasibility of Permacol Use in Infected Fields". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00820040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*